| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 8.002 | 29.622 | 34.022 | 0 | 0 | 0 | 0 | 35.329 | 34.036 | 19.545 |
| Total Income - EUR | 8.002 | 29.622 | 34.578 | 0 | 0 | 0 | 0 | 49.770 | 34.038 | 19.545 |
| Total Expenses - EUR | 834 | 10.553 | 25.133 | 9.486 | 8.714 | 6.410 | 5.217 | 33.278 | 19.861 | 12.309 |
| Gross Profit/Loss - EUR | 7.168 | 19.070 | 9.445 | -9.486 | -8.714 | -6.410 | -5.217 | 16.493 | 14.177 | 7.236 |
| Net Profit/Loss - EUR | 6.928 | 18.181 | 7.390 | -9.486 | -8.714 | -6.410 | -5.217 | 16.005 | 13.011 | 6.211 |
| Employees | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 0 |
Check the financial reports for the company - Paganini Intermed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 20.878 | 15.171 | 9.637 | 4.296 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 7.352 | 14.167 | 39.598 | 29.900 | 21.960 | 18.540 | 10.327 | 11.914 | 25.652 | 30.941 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 547 | 0 | 0 | 0 | 0 | 7 | 0 | 1.199 |
| Cash | 7.352 | 14.167 | 39.051 | 29.900 | 21.960 | 18.540 | 10.327 | 11.906 | 25.652 | 29.742 |
| Shareholders Funds | 6.973 | 18.402 | 25.481 | 15.527 | 6.512 | -21 | -5.237 | 10.751 | 23.730 | 29.808 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 379 | 16.643 | 29.288 | 24.009 | 19.744 | 18.561 | 15.565 | 1.162 | 1.923 | 1.133 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7020 - 7020" | |||||||||
| CAEN Financial Year |
4617
|
|||||||||
Comments - Paganini Intermed Srl